Clinical Trial Update: Clinical Study of Regulatory T Cells (Tregs) in the Treatment of Neurodegenerative Diseases [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating regulatory T cell therapy for amyotrophic lateral sclerosis is currently recruiting, sponsored by Novabio Therapeutics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Regulatory T Cells (Tregs) Therapy (regulatory T cells)

Snippet

Sponsor: Novabio Therapeutics | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 1 | Status: RECRUITING